HRES 342 · 119th Congress · Health

Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.

Introduced 2025-04-21· Sponsored by Rep. McGovern, James P. [D-MA-2]· House

Bill Progress

1
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2025-04-21)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 342 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. RES. 342 Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 21, 2025 Mr. McGovern submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes. Whereas diethylstilbestrol (``DES'') is a toxic and carcinogenic estrogen and endocrine disrupter; Whereas the Food and Drug Administration (``FDA'') approved DES in the early 1940s; Whereas DES was widely prescribed, with the intention of preventing miscarriage, to between five and ten million pregnant women in the United States until 1971; Whereas DES exposure in utero was linked to the development of rare cancers of the vagina and cervix called clear cell adenocarcinoma in female children, common…

Summarized by Claude AI · Non-partisan · For informational purposes only